FFA
MRNA icon

Founders Financial Alliance’s Moderna MRNA Stock Holding History

Founders Financial Alliance’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,446
Closed -$367K – 462
2021
Q4 		$367K Buy
1,446
+60
+4% +$17.5K 0.15% 156
2021
Q3 		$533K Buy
1,386
+70
+5% +$25.8K 0.25% 95
2021
Q2 		$309K Buy
+1,316
New +$235K 0.14% 165
2020
Q4 		– Sell
-1,105
Closed -$78K – 932
2020
Q3 		$78K Buy
+1,105
New +$77K 0.05% 304

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Founders Financial Alliance's MRNA Position: Q1 2022 in Review

Founders Financial Alliance sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,446 shares — an estimated $367K sold.

Founders Financial Alliance first reported a position in MRNA in Q3 2020 and held it in 4 quarters. The position peaked at $533K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Founders Financial Alliance reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Founders Financial Alliance sold 1,446 Moderna shares in Q1 2022, an estimated $367K.
  • Founders Financial Alliance first reported a position in Moderna in Q3 2020 and held it in 4 quarters.
  • Founders Financial Alliance's Moderna position peaked at $533K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Founders Financial Alliance's 13F filing for Q1 2022, filed 12 May 2022.